Neck Cancer

Canada Approved Vaccine to Prevent HPV-Related Oropharyngeal and Head and Neck Cancers

by Precisions Canada

Quebec-based Merck Canada today announced Health Canada approved an expanded indication of GARDASIL®9 in individuals 9 through 45 years of age to prevent infection caused by the Human Papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, and 58. And this approval is for Oropharyngeal and other head and neck cancers caused by HPV types 16, 18, 31, … Read more

HPV-Related Head and Neck Cancers. Meet the Authors.

by

With a dramatically increasing incidence of HPV-related head and neck cancers in North America, dentistry is the first aggressive line of defense, and now offense, in saving lives and protecting quality of life.  From this webinar, we hope that dentists will have a better understanding of the incidences, causes and epidemiology of HPV-related head and … Read more